Recherche
-
Using Population Based Kalman Estimator to Model COVID-19 Epidemic in France: Estimating the Effects of Non-Pharmaceutical Interventions on the Dynamics of Epidemic
(International Journal of Biostatistics, 2023-01-06)Article de revue -
Post-clustering difference testing: valid inference and practical considerations
(Computational Statistics and Data Analysis)Article de revueLibre accès -
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome
(Journal of Clinical Immunology. vol. 40, n° 8, pp. 1082-1092, 2020)Article de revueLibre accès -
Long-lasting severe immune dysfunction in Ebola virus disease survivors
(Nature Communications. vol. 11, n° 1, pp. 3730, 2020)Article de revueLibre accès -
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial
(Journal of Immunology. vol. 208, n° 12, pp. 2663-2674, 2022-06-15)Article de revue -
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
(iScience. vol. 24, n° 7, pp. 102711, 2021-07-23)Article de revueLibre accès -
ChatGPT and beyond with artificial intelligence (AI) in health: Lessons to be learned.
(Joint Bone Spine. vol. 90, n° 5, pp. 105607, 2023-09-01)Article de revue -
The benefit of augmenting open data with clinical data-warehouse EHR for forecasting SARS-CoV-2 hospitalizations in Bordeaux area, France
(JAMIA open. vol. 5, n° 4, 2022-12)Article de revueLibre accès -
dearseq: a variance component score test for RNA-seq differential analysis that effectively controls the false discovery rate
(NAR Genomics and Bioinformatics. vol. 2, n° 4, pp. lqaa093, 2020-11-19)Article de revueLibre accès -
Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo
(Cell Reports. vol. 42, n° 9, pp. 113101, 2023-09-26)Article de revueLibre accès